Qudsiya Karrim
latest news & developmentsA dependable lifeline for all
LifeLine received its first call on Saturday March 16 1963 in Sydney, Australia
Digital death planning for dummies
What happens to your life on the internet when you pass away? Qudsiya Karrim explores the options.
Google accused of dodgy business practices in Kenya
Google has been accused of fraudulent practice and undermining business efforts by a Kenyan mobile company.
Real help for real people
The Anglo American Chairman’s Fund is the oldest professionally managed corporate social investment programme in South Africa.
Eid-ul-Adha: Lambasting the slaughter
Eid-ul-Adha, the festival of sacrifice, has activists, Islamaphobes and Muslim vegetarians in a spin.
Starting from the top
The judges encouraged other small companies to take a leaf out of AfriSam’s book.
Raid highlights factory abuses
Apart from poor pay, scores of the predominantly female employees in the textile industry are subjected to appalling working conditions.
eThekwini’s big spenders
No one in KwaZulu-Natal knows how to flaunt it quite like Sibusiso and Shawn Mpisane.
Gang’s killing raises issue of cop violence
The deadly force by police in Durban that left six criminals dead has reignited concern about the alarming levels of police violence in KwaZulu-Natal.
Horticulture to the rescue
Schools and institutions — <b>Commendation Grootbos Private Nature Reserve</b>.
White is the new green in roofing
Energy efficiency and carbon management, sponsored by ABB — <b>Commendation: Vital Health Foods</b>.
Learning from learners
Schools and institutions — <b>Commendation: Girls and Boys Education Movement Clubs</b>.
Building on a small footprint for cement
Energy efficiency and carbon management, sponsored by ABB — Winner: <b>AfriSam South Africa</b>.
Web celebs
Given the millions of bloggers, it’s no mean feat for them to get noticed, let alone famous. But here are some who’ve catapulted to web celeb status.
GSK drops drug prices for poor nations
The world’s second-biggest drug company is cutting its prices for some countries – but not for HIV patients, writes Qudsiya Karrim.